Cheung, L. C., Cruickshank, M. N., Hughes, A. M., Singh, S., Chua, G.-A., Ford, J., Ferrari, E., Oommen, J., Malinge, S., Lock, R. B., Kees, U. R. and Kotecha, R. S. (2019) “Romidepsin enhances the efficacy of cytarabine in vivo, revealing histone deacetylase inhibition as a promising therapeutic strategy for KMT2A-rearranged infant acute lymphoblastic leukemia”, Haematologica. Pavia, Italy, 104(7), pp. e300-e303. doi: 10.3324/haematol.2018.192906.